The person, who was not authorized to talk publicly about the case and spoke to The Associated Press on the condition of anonymity, cautioned that Mangione could change his mind. If he follows through, it would be a stunning development in a case that rattled business leaders while galvanizing their critics.
Mangione’s lawyers, and spokespeople for the Justice Department and Manhattan federal prosecutors, declined to comment.
Mangione is accused of traveling to New York City to ambush Thompson, 50, then shooting him outside a Manhattan hotel on Dec. 4, 2024, as the executive walked to UnitedHealth Group’s annual investor conference.
Mangione is due in court on Friday for a hastily scheduled hearing in the federal case, which involves two counts of stalking. It wasn’t clear what charge or charges Mangione is expected to plead guilty to. The hearing, in Manhattan federal court, comes as his lawyers have been talking with federal prosecutors about a possible resolution to one of two criminal cases against Mangione in Thompson’s death. Previous talks in June broke down.
Mangione, 28, has been charged in both federal and state court in New York and still faces the possibility of a trial in his unresolved state case. Mangione’s state murder trial is set to begin Sept. 8. Both sets of charges carried the possibility of a life sentence.
